Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
VTGN similar filings
- 19 Feb 19 VistaGen Therapeutics Receives Notice of Allowance for U.S. Patent for Treatment of Depression with PH10
- 1 Feb 19 AV-101 Stimulates the Formation of New Brain Cells in Nonclinical Studies
- 15 Jan 19 VistaGen Therapeutics Appoints Pharmaceutical Industry Veteran, Ann Cunningham, to its Board of Directors
- 11 Jan 19 Regulation FD Disclosure
- 13 Dec 18 Unregistered Sales of Equity Securities
- 13 Nov 18 VistaGen Therapeutics Receives Notices of Allowance in Australia and Japan for AV-101 Patents Covering Treatment of Depression
- 30 Oct 18 VistaGen Therapeutics Reports Fiscal 2019 Second Quarter Financial Results
Filing view
External links